185 related articles for article (PubMed ID: 36586382)
1. Lateral flow assays for detection of disease biomarkers.
Gumus E; Bingol H; Zor E
J Pharm Biomed Anal; 2023 Feb; 225():115206. PubMed ID: 36586382
[TBL] [Abstract][Full Text] [Related]
2. Lateral flow assays (LFA) for detection of pathogenic bacteria: A small point-of-care platform for diagnosis of human infectious diseases.
Sohrabi H; Majidi MR; Fakhraei M; Jahanban-Esfahlan A; Hejazi M; Oroojalian F; Baradaran B; Tohidast M; Guardia M; Mokhtarzadeh A
Talanta; 2022 Jun; 243():123330. PubMed ID: 35272153
[TBL] [Abstract][Full Text] [Related]
3. An Overview for the Nanoparticles-Based Quantitative Lateral Flow Assay.
Wang Z; Zhao J; Xu X; Guo L; Xu L; Sun M; Hu S; Kuang H; Xu C; Li A
Small Methods; 2022 Jan; 6(1):e2101143. PubMed ID: 35041285
[TBL] [Abstract][Full Text] [Related]
4. QDs-based fluorescent lateral flow assays for Point-of-care testing of insulin.
Kaur J; Deng F; Morris MJ; Goldys E
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082853
[TBL] [Abstract][Full Text] [Related]
5. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing.
Gong Y; Zheng Y; Jin B; You M; Wang J; Li X; Lin M; Xu F; Li F
Talanta; 2019 Aug; 201():126-133. PubMed ID: 31122402
[TBL] [Abstract][Full Text] [Related]
6. Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.
Wang T; Chen L; Chikkanna A; Chen S; Brusius I; Sbuh N; Veedu RN
Theranostics; 2021; 11(11):5174-5196. PubMed ID: 33859741
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Urinary Biomarkers for Infectious Diseases Using Lateral Flow Assays: A Comprehensive Overview.
Patil AA; Kaushik P; Jain RD; Dandekar PP
ACS Infect Dis; 2023 Jan; 9(1):9-22. PubMed ID: 36512677
[TBL] [Abstract][Full Text] [Related]
8. Automated, Universal, and Mass-Producible Paper-Based Lateral Flow Biosensing Platform for High-Performance Point-of-Care Testing.
Han GR; Ki H; Kim MG
ACS Appl Mater Interfaces; 2020 Jan; 12(1):1885-1894. PubMed ID: 31813220
[TBL] [Abstract][Full Text] [Related]
9. Lateral flow assays for hormone detection.
Khelifa L; Hu Y; Jiang N; Yetisen AK
Lab Chip; 2022 Jun; 22(13):2451-2475. PubMed ID: 35713489
[TBL] [Abstract][Full Text] [Related]
10. Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis.
Liu Y; Zhan L; Qin Z; Sackrison J; Bischof JC
ACS Nano; 2021 Mar; 15(3):3593-3611. PubMed ID: 33607867
[TBL] [Abstract][Full Text] [Related]
11. Lateral and Vertical Flow Assays for Point-of-Care Diagnostics.
Jiang N; Ahmed R; Damayantharan M; Ünal B; Butt H; Yetisen AK
Adv Healthc Mater; 2019 Jul; 8(14):e1900244. PubMed ID: 31081270
[TBL] [Abstract][Full Text] [Related]
12. Ultrasensitive ImmunoMag-CRISPR Lateral Flow Assay for Point-of-Care Testing of Urinary Biomarkers.
Lee I; Kwon SJ; Heeger P; Dordick JS
ACS Sens; 2024 Jan; 9(1):92-100. PubMed ID: 38141036
[TBL] [Abstract][Full Text] [Related]
13. Lateral flow assays (LFA) as an alternative medical diagnosis method for detection of virus species: The intertwine of nanotechnology with sensing strategies.
Sadeghi P; Sohrabi H; Hejazi M; Jahanban-Esfahlan A; Baradaran B; Tohidast M; Majidi MR; Mokhtarzadeh A; Tavangar SM; de la Guardia M
Trends Analyt Chem; 2021 Dec; 145():116460. PubMed ID: 34697511
[TBL] [Abstract][Full Text] [Related]
14. Lateral flow assays.
Koczula KM; Gallotta A
Essays Biochem; 2016 Jun; 60(1):111-20. PubMed ID: 27365041
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the Detection Performance of Paper-Based Analytical Devices by Nanomaterials.
Pang R; Zhu Q; Wei J; Meng X; Wang Z
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056823
[TBL] [Abstract][Full Text] [Related]
16. Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests.
Majdinasab M; Badea M; Marty JL
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056148
[TBL] [Abstract][Full Text] [Related]
17. Lateral flow assay ruler for quantitative and rapid point-of-care testing.
Li Z; Chen H; Wang P
Analyst; 2019 May; 144(10):3314-3322. PubMed ID: 30968883
[TBL] [Abstract][Full Text] [Related]
18. Design of Gold Nanoparticle Vertical Flow Assays for Point-of-Care Testing.
Lei R; Wang D; Arain H; Mohan C
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626263
[TBL] [Abstract][Full Text] [Related]
19. Ultrasensitive detection of multiple Alzheimer's disease biomarkers by SERS-LFA.
Zhan Y; Fei R; Lu Y; Wan Y; Wu X; Dong J; Meng D; Ge Q; Zhao X
Analyst; 2022 Sep; 147(18):4124-4131. PubMed ID: 35971961
[TBL] [Abstract][Full Text] [Related]
20. Optical Nanobiosensor-Based Point-of-Care Testing for Cardiovascular Disease Biomarkers.
Vairaperumal T; Huang CC; Liu PY
ACS Appl Bio Mater; 2023 Jul; 6(7):2591-2613. PubMed ID: 37317822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
